BELLE Capital

Ocuphire Pharma is a clinical-stage biopharmaceutical company focused on developing and commercializing therapies for various ophthalmic disorders. Its lead product candidate, Nyxol eye drops, is a once-daily preservative-free formulation of phentolamine mesylate aimed at reducing pupil size for indications such as night vision disturbances, glaucoma, pharmacologically-induced mydriasis, and presbyopia.

Current Motor Company is an Ann Arbor, Michigan-based manufacturer specializing in electric motor scooters designed for urban commuters. The company develops and produces all-electric maxi-scooters that are zero-emission and environmentally friendly, catering to the growing demand for sustainable transportation solutions. Current Motor's scooters can reach speeds of up to 70 MPH and offer a range of approximately 50 miles on a single charge, utilizing standard household outlets for recharging. The company has established a strategic partnership with Dakkota Integrated Systems and sells its products through a network of dealers. In addition to scooters, Current Motor also manufactures electric hub motors and solar charging stations, further enhancing its commitment to energy-independent transportation options.